CRESCENT BIOPHARMA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $4.24K, a 96.74% decline year-over-year.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $5.61K, a 92.59% decline year-over-year.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $129.97K, a 325.38% increase year-over-year.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $186.77K.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2017 was $373.38K.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $114.12K, a 15.02% decline from fiscal 2014.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2014 was $134.29K, a 75.97% decline from fiscal 2013.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2013 was $558.93K, a 235736.29% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-03-31 | $4.24K 10-Q · filed 2022-11-09 | |
| 2020-06-30 | $5.61K 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $129.97K 10-Q · filed 2021-11-02 | |
| 2019-09-30 | $186.77K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $75.77K 10-Q · filed 2020-07-31 | |
| 2019-03-31 | $30.55K 10-Q · filed 2020-05-01 | |
| 2017-12-31 | $373.38K 10-K · filed 2019-03-06 | |
| 2015-12-31 | $114.12K 10-K · filed 2017-03-01 | |
| 2014-12-31 | $134.29K 10-K · filed 2017-03-01 | |
| 2013-12-31 | $558.93K 10-K · filed 2016-02-29 | |
| 2012-12-31 | $237.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |